000 01506 a2200457 4500
005 20250513035821.0
264 0 _c19951017
008 199510s 0 0 eng d
022 _a0959-4973
024 7 _a10.1097/00001813-199506000-00019
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGigante, M
245 0 0 _aEffect of cyclosporine on teniposide pharmacokinetics and pharmacodynamics in patients with renal cell cancer.
_h[electronic resource]
260 _bAnti-cancer drugs
_cJun 1995
300 _a479-82 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aBilirubin
_xmetabolism
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aCell Count
_xdrug effects
650 0 4 _aCyclosporine
_xadverse effects
650 0 4 _aFemale
650 0 4 _aGranulocytes
_xdrug effects
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPilot Projects
650 0 4 _aTeniposide
_xpharmacokinetics
700 1 _aSorio, R
700 1 _aColussi, A M
700 1 _aSandrin, A
700 1 _aDe Appollonia, L
700 1 _aGalligioni, E
700 1 _aFreschi, A
700 1 _aTalamini, R
700 1 _aToffoli, G
700 1 _aBoiocchi, M
773 0 _tAnti-cancer drugs
_gvol. 6
_gno. 3
_gp. 479-82
856 4 0 _uhttps://doi.org/10.1097/00001813-199506000-00019
_zAvailable from publisher's website
999 _c7669580
_d7669580